SESN2 and urinary bladder carcinoma: ChlA-F, a derivative of cheliensisin A [53], and isorhapontigenin, a derivative of stilbene [54], inhibit the anchorage-independent growth of bladder cancer cells by inducing sestrin-2-dependent autophagy.